The Study
Sleep characteristics of middle-aged adults with non-alcoholic fatty liver disease: findings from the Shahrekord PERSIAN cohort study
This study found that people with fatty liver disease often sleep less well — they go to bed later, nap more, or use sleeping pills. But it doesn't prove that bad sleep causes fatty liver, or that fatty liver causes bad sleep. It just shows they often happen together, like two kids who both have messy rooms — we don't know if one caused the other.
Analysis score
Maximum 44 for a cross-sectional study.
Where the score came from
People with a fatty liver often sleep worse — they sleep less efficiently, nap more, and use more sleeping pills.
Where does this study sit?
Reviews of RCTs (Meta-analyses)
Max 100Randomized Trials
Max 90Reviews of Cohort Studies
Max 85Cohort Studies
Max 72Reviews of Case-Control Studies
Max 63Case-Control Studies
Max 58Cross-Sectional & Case Series
Max 50Expert Opinion
Max 544 / 100
Quality score
Snapshots of a population at a single point in time, or descriptions of small groups. Can identify correlations and prevalence, but cannot determine cause and effect.
Key takeaways
Summary
Based on the study abstract and findings.
- 1Yes — even after accounting for weight and metabolism, poor sleep and sleeping pills still linked to fatty liver, suggesting sleep matters beyond just being overweight.
- 2For every 10% drop in sleep efficiency, risk of fatty liver goes up 8%.
- 3People who take sleeping pills have 48% higher risk.
- 4Napping raises risk in men and lean people, but not in women or obese people.
Score breakdown, methodology, conflicts of interest, evidence analysis & raw study data
Publication
Journal
BMC Public Health
Year
2023
Authors
Elaheh Zarean, Mehdi Azizmohammad Looha, Payam Amini, A. Ahmadi, P. Dugué
Related Content
Claims (6)
People with better sleep quality have a 29% lower risk of developing non-alcoholic fatty liver disease.
Middle-aged adults with lower sleep efficiency have a higher rate of non-alcoholic fatty liver disease, and for every 10% reduction in sleep efficiency, the relative risk of the disease increases by 8% after accounting for age, sex, body weight, metabolic health, and lifestyle factors.
Among adults aged 40 and older, lower sleep efficiency is linked to higher levels of liver fat compared to adults under 40, and this link is stronger in older age groups.
In middle-aged adults, daytime napping is linked to non-alcoholic fatty liver disease in men and those with a BMI below 30, but not in women or those with a BMI of 30 or higher.
Middle-aged adults who use sleeping pills have a 48% higher rate of non-alcoholic fatty liver disease compared to those who do not, even after accounting for age, sex, body weight, metabolic health, and lifestyle factors.
Middle-aged adults who go to bed after midnight have a higher rate of non-alcoholic fatty liver disease, but this link is entirely due to other factors like diet, physical activity, and metabolic health. When these factors are accounted for, bedtime alone has no independent effect on liver fat levels.
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.